GlobalData conducts research that informs government and payer policy on value-based healthcare and improving access to treatment. The reports available here for download, along with links to other published studies, share the common goal of demonstrating how strategic interventions can reduce medical costs, increase productivity, improve quality of life, lower mortality rates, address health inequities, and optimize pricing, reimbursement, and access strategies. The latest white paper on drug shortages (below) explores the root causes, policy responses, and strategic recommendations to enhance access and mitigate future supply disruptions. Additional studies on the economic burden of obesity and the value of treatment can be found here. For more information, contact
Consulting@globaldata.com
